April 1, 2021
Ad Scientiam was selected by the Ile-de-France Regional Council under the PM'up program.
Ad Scientiam's digital biomarkers development project is indeed part of the #Leader strategy developed by the Regional Council to promote growth, employment, and innovation in Ile-de-France.
Ad Scientiam was selected by a jury of French and German experts for the French Healthcare Booster Germany program, aimed at developing our activities in Germany.
March 9, 2023
MSCopilot® development was selected for innovation support under the Innov'up Leader PIA program, funded by the State and Île-de-France Region.
August 13, 2020
We announce the enrollment of the First Patient In in the HARMONY 360 study, conducted in collaboration with Merck KGaA, Darmstadt, Germany, to explore multimodal remote digital monitoring of generalized Myasthenia Gravis with MyoSense 360.
October 8, 2026
Talk to our experts and discover how our solutions integrate into your practice or studies.
This site uses analytics cookies
We use Countly to measure audience and improve your experience. This data remains anonymous and is not shared with third parties.